Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial
Titel:
Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial
Auteur:
Eggermont, Alexander MM Kicinski, Michal Blank, Christian U. Mandala, Mario Long, Georgina V. Atkinson, Victoria Dalle, Stéphane Haydon, Andrew Meshcheryakov, Andrey Khattak, Adnan Carlino, Matteo S. Sandhu, Shahneen Larkin, James Puig, Susana Ascierto, Paolo A. Rutkowski, Piotr Schadendorf, Dirk Boers-Sonderen, Marye Di Giacomo, Anna Maria van den Eertwegh, Alfonsus JM Grob, Jean-Jacques Gutzmer, Ralf Jamal, Rahima van Akkooi, Alexander C.J. Lorigan, Paul Grebennik, Dmitri Kreplere, Clemens Marreaud, Sandrine Suciu, Stefan Robert, Caroline